scholarly journals The Search for a Predictor of CD4 Cell Count Continues: Total Lymphocyte Count Is Not a Substitute for CD4 Cell Count in the Management of HIV-Infected Individuals in a Resource-Limited Setting

2004 ◽  
Vol 39 (4) ◽  
pp. 579-581 ◽  
Author(s):  
N. O. Akinola ◽  
O. Olasode ◽  
I. A. Adediran ◽  
O. Onayemi ◽  
A. Murainah ◽  
...  
Keyword(s):  
Cell Count ◽  
Lymphocyte Count ◽  
Total Lymphocyte Count ◽  
Resource Limited Setting ◽  
Cd4 Cell Count ◽  
Total Lymphocyte ◽  
Resource Limited ◽  
Cd4 Cell ◽  
Limited Setting

scholarly journals The Role of Aerosol Pentamidine Prophylaxis

1993 ◽  
Vol 4 (2) ◽  
pp. 67-69
Author(s):  
E L C Ong
Keyword(s):  
Cell Count ◽  
Pneumocystis Carinii Pneumonia ◽  
Lymphocyte Count ◽  
Pneumocystis Carinii ◽  
Total Lymphocyte Count ◽  
First Episode ◽  
Cd4 Cell Count ◽  
Drug Of Choice ◽  
Cd4 Cell

Pneumocystis carinii pneumonia (PCP) is the most frequent opportunistic infection in patients with AIDS, occurring in 80% and recurring in 50% of patients within 12 months of the first episode. Prophylaxis for PCP is recommended if the CD4+ cell count is <200×106/l or 20% of the total lymphocyte count, or after an episode of PCP. The most effective prophylactic agent currently is trimethoprim-sulphamethoxazole and should be the drug of choice but alternatives such as aerosol pentamidine are being increasingly used for patients who cannot tolerate this combination or other oral preparations. If aerosol pentamidine is used and administered via a Respigard II Marquest nebulizer, the dosage should be higher than the currently recommended monthly dosage of 300 mg.

Sign in / Sign up

Export Citation Format

Share Document